Both in Ophthalmic Goods
RxSight vs National Vision Holdings
Over the past year RXST returned −45.8% and EYE returned −36.4%; their daily moves had a correlation of 0.21.
RXST −45.8% EYE −36.4%Growth of $1, one year, split-adjusted
| Metric | RXST | EYE |
|---|---|---|
| Price | $4.71 | $16.77 |
| Market cap | $195.7M | $1.33B |
| Today | −1.98% | −2.10% |
| 1 month | −1.2% | +1.5% |
| 6 months | −35.2% | −25.3% |
| Year to date | −54.8% | −35.1% |
| 1 year | −46.5% | −34.9% |
| Revenue growth (YoY) | +0.3% | +2.5% |
| Gross margin | 76.7% | 58.2% |
| Net margin | −35.9% | 2.5% |
| P/E (TTM) | — | 26.4× |
| Price / sales | 1.5× | 0.7× |
| Net cash | $208.8M | -$201.7M |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 52.2% |
| Short % of float | 10.5% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).